Marijuana Reform Emerges as 2026 Midterm Elections Issue Across Parties

Federal Rescheduling Timeline Drives Campaign Messaging

Candidates in competitive House and Senate races are referencing the DEA's ongoing rescheduling review as they outline positions on cannabis policy. The agency's proposed rule to move cannabis from Schedule I to Schedule III under the Controlled Substances Act remains under final review, with no published effective date as of August 15, 2026. Democratic candidates in Pennsylvania, Arizona, and Nevada have called for expedited implementation. Republican challengers in those states have emphasized state-level control and opposition to federal mandates.

The rescheduling proposal doesn't legalize cannabis for recreational use or remove it from the CSA entirely. It would eliminate the application of IRC §280E to state-licensed cannabis operators, allowing ordinary business deductions for cost of goods sold and operating expenses. That tax change carries an estimated $5 billion annual impact on operator cash flow, according to industry financial models.

On a strict reading of the proposed rule, rescheduling wouldn't resolve conflicts between state-licensed operations and federal prohibitions on distribution or possession outside the research and medical pathways established under Schedule III.

SAFER Banking Act Remains Stalled in House

The Senate-passed SAFER Banking Act hasn't advanced to a House floor vote, creating a campaign contrast point in districts with significant cannabis industry employment. The bill passed the Senate 58-42 in September 2025. It would provide a federal safe harbor for depository institutions serving state-licensed cannabis businesses. House leadership hasn't scheduled a vote, and the measure isn't expected to move before the November 2026 election.

Democratic incumbents in California, Colorado, and Michigan have criticized the delay, framing banking access as a public-safety issue tied to cash-dependent operations. Republican candidates in the same districts have split: some endorse the banking provisions while opposing broader legalization, others reject any federal accommodation of state-licensed cannabis commerce.

The SAFER Banking Act doesn't address IRC §280E or provide access to federal bankruptcy protections. It narrowly targets the Bank Secrecy Act and related anti-money-laundering statutes to permit financial institutions to serve cannabis operators without federal enforcement risk.

State Ballot Measures Add Local Campaign Pressure

Six states have cannabis-related measures on the November 2026 ballot, forcing candidates to declare positions on legalization and taxation frameworks. Florida's Amendment 3 would authorize adult-use sales and impose a 10% state excise tax on retail transactions. Ohio's Issue 2 would expand the existing medical program to include adult-use licenses and establish a 15% combined state and local tax. North Dakota's Measure 5 would legalize possession and home cultivation without establishing a commercial market.

Candidates in those states face direct voter questions on cannabis policy, with polling showing support above 55% for the Florida and Ohio measures and narrower margins in North Dakota. Arkansas, South Dakota, and Oklahoma have medical-expansion or decriminalization measures. These draw less campaign attention but still require candidate responses in forums and debates.

State measures operate independently of federal scheduling or banking law. Passage wouldn't alter the applicability of IRC §280E to operators in those states unless and until DEA finalizes the rescheduling rule.

Campaign Finance Data Shows Industry Contributions Rising

Cannabis industry PACs and executives contributed $8.3 million to federal candidates in the first half of 2026, a 34% increase over the same period in the 2024 cycle. The National Cannabis Roundtable, the Cannabis Trade Federation, and state-level operator groups have directed contributions to candidates in competitive races who have endorsed the SAFER Banking Act or rescheduling. Republican recipients include incumbents in Florida, Texas, and Montana who have supported banking reform while opposing full legalization.

Democratic recipients include challengers in Arizona, Pennsylvania, and Wisconsin who have called for descheduling cannabis entirely and expunging prior convictions. The contribution pattern reflects the industry's bipartisan strategy: secure incremental federal reforms like banking and tax relief while advancing state-level legalization through ballot measures and legislative action.

Federal campaign finance rules treat cannabis industry contributions the same as any other sector. Contributions from individuals employed by state-licensed operators are permissible; corporate contributions remain prohibited under 52 U.S.C. §30118.

What to Watch Through November

Three variables will determine whether cannabis policy remains a midterm issue or fades before Election Day. First, the DEA's publication of a final rescheduling rule would shift the debate from hypothetical to operational, forcing candidates to address implementation timelines and tax implications. A House floor vote on the SAFER Banking Act—unlikely but possible—would create a recorded vote that challengers could use in campaign advertising. Third, polling trends in the six states with ballot measures will signal whether candidates in those states continue to emphasize cannabis or pivot to other issues.

We'll be watching for the DEA's final rule publication, any movement on SAFER Banking in the House, and polling shifts in ballot-measure states as campaigns enter the final stretch.

For full background on this story, see the CannIntel topic hub on 2026 Midterm Elections and Cannabis Reform.